Agencies rock for a good cause at Pharmapalooza

Share this article:
Agencies rock for a good cause at Pharmapalooza
Agencies rock for a good cause at Pharmapalooza

Corbett Accel Healthcare Group can add music to its list of creative achievements after its Chicago office triumphed in last night's Pharmapalooza “battle of the bands” contest at B.B. King's Blues Club & Grill in New York City.

Heavy Medical — comprising Jeff Holtorf (drums), Terry Barich (harmonica, vocals), Brian Catral (keyboards, vocals), Jack Cunningham (bass, vocals), Joe Mason (theremin, vocals), Matt Pearl (guitar, vocals) Nicole Stachura (percussion, vocals) and Kelly Christiansen (percussion, vocals) — rocked a sell-out crowd of 750 vociferous industry colleagues and supporters.

In second place was Late Night Car Service (a.k.a. Sudler & Hennessey) which got the vote from MM&M's unofficial panel in attendance. But the real winners of the charity event, which was conceived and organized by New York-based Cline Davis & Mann, was the Children's Hospital at Montefiore, for whom more than $110,000 was raised.

Other contestants were May Cause Nausea (Ogilvy Healthworld), Grand pRx (GSW Worldwide), Pharmatopia (Corbett Accel New York), Mr. Tiny's Revenge (Grey Healthcare Group), SIDEFX (Regan Campbell Ward • McCann), BANDRx (AgencyRx) and Black Box Warning (Harrison & Star). CDM had set the tone with an impressive opening set from its 21-member ensemble, Uncle Funkus.

 

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.